Abstract
Antimicrobial resistance has been a problem for the treatment of gonorrhoea since the introduction of sulfa drugs in the 1930s. The gonococcus has a remarkable ability to obtain the genetic elements required to develop resistance and for these resistant strains to then widely disseminate. Many decades of antibiotic monotherapy have seen the introduction of a number of antibiotic classes herald a promising new era of treatment only to subsequently fail due to resistance development. The world is now faced with the prospect of extensively resistant Neisseria gonorrhoea and requires a coordinated action plan to detect and treat these resistant strains.
| Original language | English |
|---|---|
| Pages (from-to) | 57-62 |
| Number of pages | 6 |
| Journal | Microbiology Australia |
| Volume | 40 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - May 2019 |